Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways

INTRODUCTION: The aim of our research was to investigate changes in the molecular background of the immune response in the chronic phase (CP) of chronic myeloid leukaemia (CML) during treatment with tyrosine kinase inhibitors (TKIs). METHODS: Global gene and miRNA expression profiles were assessed u...

Descripción completa

Detalles Bibliográficos
Autores principales: Janowski, Michał, Ulańczyk, Zofia, Łuczkowska, Karolina, Sobuś, Anna, Rogińska, Dorota, Pius-Sadowska, Ewa, Gniot, Michał, Kozłowski, Krzysztof, Lewandowski, Krzysztof, Helbig, Grzegorz, Machaliński, Bogusław, Paczkowska, Edyta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553433/
https://www.ncbi.nlm.nih.gov/pubmed/36238136
http://dx.doi.org/10.2147/OTT.S371847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553433/
https://www.ncbi.nlm.nih.gov/pubmed/36238136
http://dx.doi.org/10.2147/OTT.S371847

Ejemplares similares